Skip to Main Content

2023 - 2024 Respiratory Syncytial Virus (RSV) Season Changes

Date: 03/21/24

The Texas Health and Human Services Commission (HHSC) closed the 2023 - 2024 Respiratory Syncytial Virus (RSV) season’s Synagis prophylaxis therapy for all regions on March 15, 2024. The RSV season began in various regions between October 2, 2023, and November 1, 2023. For additional information regarding start and end dates for all regions, please refer to the HHSC 2023-24 Synagis Prior Authorization Schedule.

HHSC based this decision on the recommendation of the Texas RSV task force and the HHSC Office of the Medical Director (OMD), due to the continued decrease in RSV test positivity in the past two consecutive weeks. HHSC, in collaboration with the RSV task force and OMD, will continue to monitor RSV activities and notify the public about any updates needed to allow access to Synagis prophylaxis treatments.

HHSC does not cover RSV vaccines through pharmacy benefits, and this notice does not impact the vaccination of eligible members through the Texas Vaccine Program.

For questions, please contact Pharmacy Services at 1-866-768-7147, ext. 6072804.